Exploration of the In Vitro Violacein Synthetic Pathway with Substrate Analogues

Area of Science:

• Biochemistry
• Synthetic Biology
• Enzymology

Background:

• Enzymes offer precise synthesis of small molecules.
• Extending enzyme substrate scope is crucial for producing novel analogues.
• Enzyme promiscuity is desired for broader synthetic applications.

Purpose of the Study:

• To investigate enzyme promiscuity in the violacein biosynthetic pathway using tryptophan analogues.
• To determine the substrate scope limitations of the VioA enzyme and the complete violacein cascade.
• To understand the compatibility of enzyme promiscuity within multi-enzyme systems.

Main Methods:

• In vitro screening of nine tryptophan analogues with the VioA enzyme.
• Analysis of substrate conversion and product formation.
• Testing successful VioA substrates in the five-enzyme violacein cascade (VioABEDC).

Main Results:

• VioA showed promiscuity, accepting seven of nine tryptophan analogues, with substitutions at the 2- or 4-position being non-viable.
• Only L-tryptophan and 6-fluoro-L-tryptophan were converted to violacein derivatives by the full VioABEDC cascade.
• Several analogues were converted to intermediate products, indicating pathway-specific limitations.

Conclusions:

• The initial enzyme (VioA) exhibits substrate promiscuity, but the multi-enzyme violacein pathway demonstrates significantly less adaptability.
• Successful analogue conversion in multi-enzymatic cascades requires compatible promiscuity across all constituent enzymes.
• This study highlights the challenges in expanding enzymatic product scope within complex biosynthetic pathways.